Finance

Lists
ORMP:TLV
Oramed Pharmaceuticals, Inc.
ILA 1,500.00
-6.25%
(-100.00) 1D
Aug 28, 5:26:00 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for ORMP...
Open
ILA 1,600.00
High
ILA 1,600.00
Low
ILA 1,500.00
Mkt. cap
210.48M
Avg. vol.
6.55K
Volume
5.65K
52-wk high
ILA 1,742.00
52-wk low
ILA 700.10
Shares outstanding
41.60M
No. of employees
13
Open
ILA 1,600.00
High
ILA 1,600.00
Low
ILA 1,500.00
Mkt. cap
210.48M
Avg. vol.
6.55K
Volume
5.65K
52-wk high
ILA 1,742.00
52-wk low
ILA 700.10
Shares outstanding
41.60M
No. of employees
13
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.
CEONadav Kidron
Employees13
Founded2006
Headquarters-
SectorPharmaceutical industry
Websiteoramed.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.15M
1.99M
1.59M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.27M
3.68M
2.06M
2.77M
Operating expense
2.43M
5.67M
3.66M
2.77M
Total operating expenses
2.43M
5.67M
3.66M
2.77M
Operating income
-2.43M
-5.67M
-3.66M
-2.77M
Other non operating income
408.00K
-313.00K
8.15M
606.00K
EBT including unusual items
59.45M
9.80M
49.44M
101.59M
EBT excluding unusual items
-1.51M
-5.90M
4.72M
-2.06M
Income tax expense
11.06M
-212.00K
11.13M
23.43M
Effective tax rate
18.61%
-2.16%
22.51%
23.06%
Other operating expenses
-
-
-
-
Net income
48.40M
10.01M
38.31M
78.16M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
509.00K
337.00K
276.00K
98.00K
Interest expense
-
-
-
-
Net interest expenses
509.00K
337.00K
276.00K
98.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.40M
-5.64M
-3.63M
-2.74M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps